David W. Wilbur, MD, PhD
The Editors welcome submissions for possible publication in the Letters section. Authors of letters should:
•Include no more than 300 words of text, three authors, and five references
•Type with double-spacing
•Send three copies of the letter, an authors' form signed by all authors, and a cover letter describing any conflicts of interest related to the contents of the letter.
Letters commenting on an Annals article will be considered if they are received within 6 weeks of the time the article was published. Only some of the letters received can be published. Published letters are edited and may be shortened; tables and figures are included only selectively. Authors will be notified that the letter has been received. If the letter is selected for publication, the author will be notified about 3 weeks before the publication date. Unpublished letters cannot be returned.
Annals welcomes electronically submitted letters.
Wilbur D.; Drug Legalization, Harm Reduction, and Drug Policy. Ann Intern Med. 1996;124:776. doi: 10.7326/0003-4819-124-8-199604150-00017
Download citation file:
Published: Ann Intern Med. 1996;124(8):776.
TO THE EDITOR:
DuPont and Voth's defense of the status quo in drug policy  begs for some response. The selective use of statistics, especially those derived from a private source, is unconvincing. The insinuation that persons who disagree with current policy do so because of a personal drug habit is pejorative, cannot be clearly evaluated, and sidesteps the issues. In fact, several large groups have strong incentives to assert a need to maintain the current system, including persons making a living on the government side of the current “war on drugs” and those who profit by supplying drugs in the current price-supported environment.
to gain full access to the content and tools.
Learn more about subscription options.
Register Now for a free account.
Copyright © 2016 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use
This PDF is available to Subscribers Only